MiMedx Group Inc reports results for the quarter ended in March - Earnings Summary

MiMedx

01/05/2024 21:13

* MiMedx Group Inc  MDXG.OQ  reported quarterly adjusted
earnings
of 7 cents​​ per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -6 cents.  The mean expectation of six analysts for the
quarter was for earnings of 5 cents per share. Wall Street
expected results to range from 3 cents to 6 cents per share.
    * Revenue rose 18.2% to $84.71 million from a year ago;
analysts
expected $79.36 million. 
    * MiMedx Group Inc's reported EPS for the quarter was 6
cents​.
    * The company reported quarterly net income of $9.06
million.
    * MiMedx Group Inc shares had fallen by 20.0% this
quarter and
lost 29.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MiMedx Group Inc
is $12.50 
This summary was machine generated from LSEG data May 1 at 08:13
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.05           0.07           Beat
 Dec. 31 2023      0.07           0.32           Beat
 Sep. 30 2023      0.05           0.06           Beat
 Jun. 30 2023      -0.02          0.00           Beat